ACM
ACT Capital Management Portfolio holdings
AUM
$72.5M
This Quarter Return
-12.64%
1 Year Return
-33.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$94.5M
AUM Growth
+$94.5M
(-32%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-14.68%
Top 10 Holdings %
Top 10 Hldgs %
63.27%
Holding
99
New
7
Increased
9
Reduced
25
Closed
14
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.23M |
| 2 |
Devon Energy
DVN
|
$2.63M |
| 3 |
Lantheus
LNTH
|
$2.21M |
| 4 |
DigitalOcean
DOCN
|
$1.19M |
| 5 |
Stratasys
SSYS
|
$1.14M |
Top Sells
| 1 |
Arcturus Therapeutics
ARCT
|
$6.1M |
| 2 |
United Therapeutics
UTHR
|
$2.92M |
| 3 |
Meta Platforms (Facebook)
META
|
$2.52M |
| 4 |
Vir Biotechnology
VIR
|
$2.43M |
| 5 |
STAAR Surgical
STAA
|
$1.6M |
Sector Composition
| 1 | Healthcare | 76.17% |
| 2 | Technology | 13.28% |
| 3 | Energy | 4.44% |
| 4 | Communication Services | 1.63% |
| 5 | Industrials | 1.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $19M | 20.13% | 238,100 -20,000 | -8% | -$1.6M |
|
2
Arrowhead Research
ARWR
$3.05B
| $9.24M | 9.78% | 201,000 -9,500 | -5% | -$437K |
|
|
3
Arcturus Therapeutics
ARCT
$462M
| $6.83M | 7.23% | 253,300 -226,100 | -47% | -$6.1M |
|
4
Clearside Biomedical
CLSD
$28.9M
| $5.63M | 5.96% | 2,458,600 -24,900 | -1% | -$57K |
|
|
5
NVIDIA
NVDA
$4.24T
| $4.23M | 4.47% | +15,500 | New | +$4.23M |
|
6
Krystal Biotech
KRYS
$4.27B
| $3.93M | 4.15% | 59,000 | – | – |
|
|
7
Stratasys
SSYS
$906M
| $3.52M | 3.72% | 138,500 +45,000 | +48% | +$1.14M |
|
|
8
Devon Energy
DVN
$22.9B
| $2.63M | 2.78% | +44,500 | New | +$2.63M |
|
9
enVVeno Medical
NVNO
$15.4M
| $2.56M | 2.7% | 401,200 +138,700 | +53% | +$884K |
|
|
10
Lantheus
LNTH
$3.73B
| $2.21M | 2.34% | +40,000 | New | +$2.21M |
|
|
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.08M | 2.2% | 250,000 +91,500 | +58% | +$759K |
|
12
IDEAYA Biosciences
IDYA
$2.15B
| $1.94M | 2.05% | 173,500 | – | – |
|
13
INmune Bio
INMB
$54M
| $1.94M | 2.05% | 230,500 | – | – |
|
14
Inhibikase Therapeutics
IKT
$134M
| $1.59M | 1.69% | 1,076,500 | – | – |
|
15
Adtran
ADTN
$751M
| $1.57M | 1.66% | 85,000 -30,000 | -26% | -$553K |
|
|
16
DigitalOcean
DOCN
$2.97B
| $1.45M | 1.53% | 25,000 +20,500 | +456% | +$1.19M |
|
17
AirSculpt Technologies
AIRS
$403M
| $1.39M | 1.47% | 101,500 | – | – |
|
|
AFMD
18
DELISTED
Affimed
AFMD
| $1.35M | 1.43% | 308,800 | – | – |
|
|
ICAD
19
DELISTED
iCAD Inc
ICAD
| $1.31M | 1.39% | 294,500 -29,600 | -9% | -$132K |
|
20
fuboTV
FUBO
$1.21B
| $1.26M | 1.33% | 192,000 -38,500 | -17% | -$253K |
|
|
QTEK
21
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
| $1.14M | 1.2% | +354,269 | New | +$1.14M |
|
|
MYOV
22
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.13M | 1.2% | 85,000 | – | – |
|
|
AWH
23
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $1.04M | 1.1% | 1,000,000 | – | – |
|
24
Zeta Global
ZETA
$4.68B
| $924K | 0.98% | 72,500 -62,500 | -46% | -$797K |
|
25
Range Resources
RRC
$8.16B
| $911K | 0.96% | +30,000 | New | +$911K |
|